TIES | $1,500,000 | (Apr 30, 2026)
Certifyde | $2,000,000 | (Apr 30, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Certified by Founder
Lodge
DotBio
start up
Singapore
- Singapore
- 07/08/2023
- Pre Series A
- $5,600,000
DotBio is focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, its proprietary DotBody technology. DotBodies are domain therapeutic antibodies which are multi-specific, humanized and highly-stable. The company was founded by Professor Pär Nordlund and Dr. Ignacio Asial, who designed and conceptualized the DotBody technology based on their expertise in protein and antibody engineering at Singapore’s Nanyang Technological University. For more information visit www.dotbiopharma.com
- Industry Biotechnology Research
- Website https://www.dotbio.com/
- LinkedIn https://www.linkedin.com/company/dotbio/about/
Skyfire | AI | $11,000,000 | (Apr 30, 2026)
General Analysis | $10,000,000 | (Apr 30, 2026)
Fence | $20,000,000 | (Apr 30, 2026)
Tacalyx GmbH | $12,843,270 | (Apr 30, 2026)
OpenObserve | $10,000,000 | (Apr 30, 2026)
Crazy Mountain | $15,000,000 | (Apr 30, 2026)
Windmill(US) | $12,000,000 | (Apr 29, 2026)
Hypervision Surgical | $22,962,410 | (Apr 29, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)